EMA Recommends Revocation Of Marketing Authorization For Amgen's Tavneos

Benzinga Newsdesk www.benzinga.com Neutral 94.7%

Neg 0% Neu 94.7% Pos 0%

https://www.ema.europa.eu/en/documents/referral/tavneos-article-20-procedure-ema-recommends-revoking-marketing-authorisation-tavneos_en.pdf